Hematologic Neoplasms

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)

Mind-body Medicine for Patients With Malignant Hematological Diseases

UWCCC Molecular Tumor Board Registry

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

Optimizing PTCy Dose and Timing

Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy

Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients

TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia

A Multi-center Investigation of Family Health.

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation